PRESS RELEASE published on 02/05/2026 at 00:00, 3 months 12 days ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus Onco-Innovations Limited announces filing of preliminary base shelf prospectus with securities regulatory authorities in several provinces for potential future offerings. Company focuses on cancer research and treatment Forward-looking Statements Cancer Research Securities Offering Base Shelf Prospectus Onco-Innovations Limited
PRESS RELEASE published on 02/04/2026 at 22:25, 3 months 12 days ago 55 North Mining Announces Flow-Through Financing 55 North Mining Inc. announces a non-brokered flow-through private placement to fund exploration at Last Hope Gold Project in Manitoba, Canada. No warrants issued. Exploration drilling in progress Private Placement Exploration Canada 55 North Mining Inc. Last Hope Gold Project
PRESS RELEASE published on 02/04/2026 at 22:00, 3 months 12 days ago Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Inventiva to present at Guggenheim Emerging Outlook: Biotech Summit 2026. CEO Andrew Obenshain to participate in fireside chat on February 11, 2026, in New York City Fireside Chat Inventiva Biotech Summit Guggenheim Emerging Outlook CEO Andrew Obenshain
PRESS RELEASE published on 02/04/2026 at 22:00, 3 months 12 days ago Inventiva présentera au Guggenheim Emerging Outlook : Biotech Summit 2026 Inventiva présentera au Guggenheim Emerging Outlook : Biotech Summit 2026. Andrew Obenshain participera à un 'fireside chat' lors de l'événement à New York. A propos d'Inventiva et détails de la conférence disponibles Inventiva MASH Lanifibranor Biotech Summit Guggenheim
PRESS RELEASE published on 02/04/2026 at 20:54, 3 months 12 days ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025 Elmos Semiconductor SE plans to distribute 36 million Euro to shareholders for fiscal year 2025 through share buyback program and dividend increase of 50%. Company emphasizes sustainable capital allocation and successful development Share Buyback Dividend Increase Capital Allocation Elmos Semiconductor SE Fiscal Year 2025
PRESS RELEASE published on 02/04/2026 at 20:36, 3 months 12 days ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025 Elmos Semiconductor SE approves 10 million Euro share buyback program via stock exchange and proposes 1.50 Euro per share dividend for 2025 Share Buyback Stock Exchange Dividend Proposal Elmos Semiconductor SE Fiscal Year 2025
PRESS RELEASE published on 02/04/2026 at 20:00, 3 months 12 days ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee Belgium's Ingmar De Vos elected to the Executive Board of the International Olympic Committee as representative of Summer Olympic Federations. De Vos expresses gratitude and commitment to Olympic Movement Ingmar De Vos Olympic Movement IOC Executive Board ASOIF President Summer Olympic Federations
PRESS RELEASE published on 02/04/2026 at 20:00, 3 months 12 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Claranova SE publie le nombre d'actions et de droits de vote au 31 janvier 2026, conformément aux règlementations en vigueur Communication Financière Droits De Vote Capital Social Actions Claranova SE
PRESS RELEASE published on 02/04/2026 at 19:53, 3 months 12 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement on total voting rights and shares. Company focuses on innovative medicines in rare diseases with lipid science expertise Shares Total Voting Rights Monthly Statement ABIONYX Pharma Innovative Medicines
PRESS RELEASE published on 02/04/2026 at 19:53, 3 months 12 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre total de droits de vote et d'actions en circulation, soulignant son engagement envers les maladies inflammatoires sévères sans traitement efficace Droits De Vote Actions Maladies Inflammatoires Biopharma ABIONYX Pharma
Published on 05/16/2026 at 01:15, 1 day 14 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 15 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 16 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 16 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 23 hours 8 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 19 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 21 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 5 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 6 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 21 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES